For healthcare professionals only


University of Toronto is criticised for study of homeopathy in ADHD

BMJ 2015; 350 doi: (Published 05 March 2015) Cite this as: BMJ 2015;350:h1234
  1. Owen Dyer
  1. 1Montreal

A study by University of Toronto researchers looking at homeopathic treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) has been criticised in a letter signed by 90 scientists and doctors. They say they are concerned that “the mounting of such a study by a highly reputable researcher at a top notch university will be used by homeopaths to justify diverse aspects of their practice, including steering patients away from evidence-based treatments.”

The trial, which is registered with the US National Institutes of Health,1 is being conducted by a team led by the dean of the Leslie Dan Faculty of Pharmacy, Heather Boon. It is currently recruiting 177 patients aged 6 to 16 years into three double blinded treatment arms: homeopathic consultation and medicine, homeopathic consultation and placebo, and a no treatment group.

The letter originated in the Office for Science and Society of McGill University …

View Full Text

Log in

Log in through your institution


* For online subscription